Top of page Skip navigation

    Early Bird fees available until 25 August


    Join us in Cardiff on 29 and 30 November 2017


Presentations from the 2016 conference

Day One

Fergal O’Brien - Welcome 
Ian McCubbin - Medicines Manufacturing in the UK
Dr Jim Faulkner - The potential impact of the Taskforce recommendations on a UK T-cell therapy SME
Dr James Miskin - Lentiviral vector manufacturing strategies to supply the market
Sharon Grimster - Why did ReNeuron invest in a UK manufacturing facility

Professor Nigel Titchener-Hooker - Peter Dunnill Award Lecture  - Processing Priorities of the Future – Lessons learnt and Future Challenges


Workshop one - Current analytical challenges across the medicine manufacturing space

Professor Paul Dalby Analytical challenges in protein formulation
Professor Melissa Hanna-Brown - Securing a Healthy Future for Chemical and Bio Analytical Measurement Science (AMS) in the UK
Dr Damian Marshall - Current Analytical Challenges across the Medicines Manufacturing Space


Workshop two - Medicines manufacturing and supply innovation

Simon Barnes and  Alan Johnston - Contextualised data and digital readiness – a perspective on Industry 4.0
Dr Mark Bustard - Medicines manufacturing and supply innovation
Hans Johansson - Addressing industrial needs for cost effective MAb purification with a new range of Protein A agarose resins
Dr Jagjit Singh Srai - Perspectives on Future Pharmaceutical Supply Chains
Ian Rees - MHRA Support for Innovation


Workshop three- Gene Therapy Resurgence

Julian Hanak - Gene Therapy Resurgence
Professor Michael Linden - Gene Therapy -  next stop Pharma
Professor Adrian Thrasher - Evolving Gene therapy in Severe Immunodeficiency


Day Two

Next generation antibody molecules
Dr Paul Varley -  Next generation antibody molecules
Dr Dave Simpson - The rapidly growing pipeline of Antibody Drug Conjugates (ADCs) requires a toolbox approach to problem solving and the safe development of this complex product class
Dr Mike Davis - Bispecific antibodies - new opportunities for novel therapies
Dr Caroline Barelle - soloMERsTM; Site-specific therapeutic biologics for the treatment of inflammatory disease


Technologies to deliver the future
Dr Michael L Roberts - Developing synthetic promoters for bioprocessing applications
Profesor Tim Dafforn - Nanoencapsulation of membrane proteins for drug discovery and more
Dr Dirk Voelkel - Brilliant machines, big data analytics, industrial internet and Bioprocessing
Dr David Pollard - Progress towards automated continuous biologics production with real time release